You're watching...

When Will Inflation Kick In?

Details

  • Description

    Margie Patel, Wells Fargo Advantage Funds senior portfolio manager, gives her markets and earnings outlook.

  • Duration 4:03
  • Date

Clips

Also in this playlist...

Latest Video

Auto-advance: ON

Auto-advance

Transcript

This transcript is automatically generated

Minutes now.

While we're saying a major indices are up roughly 10%.

For the year not bad 14% on the recipes how should investors position themselves for the rest of 2012 still a lot of uncertainty out there -- joining us now.

Wells capital.

From senior portfolio manager Margie Patel money.

I was looking through your notes and you said look QE3.

Doing nothing except raising inflation -- be prepared for that but I've been hearing this from analysts for some time.

Where QE3 we -- -- seeing signs of that so when do you see inflation kicking in.

I think we need to see much stronger lending from the banks in order to really super power all -- the -- even as they are I think over the next year inflation will be low.

So that's really -- concern down the road off for today you know.

When things you also point out is that people are better -- suited with companies that make their money here in the United States we actually heard in some earnings reports recently even G saying.

The currency.

Exchange is part of what killed them.

So do you recommend that people swap that of the multinationals into US based companies.

While I think the US space.

Companies companies have most of their revenues in the US will do better.

Because one of the big sources of growth over the last few years has been selling to developing markets.

But now -- seeing those growth rates are coming -- very dramatically whether it's China India Brazil.

So that our grocery doesn't look that bad after all and we have a great fundamental also I think you're going to see surprises for US based companies.

Who have less emphasis in those rapidly growing areas of really salaries.

-- -- -- -- -- global areas and it with the global economy slowing down so much many of these companies do have exposure to the rest of the world Caterpillar just one announcing today how tough it is.

How bad.

So what does that -- you for the markets going Ford into the new year will have the election behind us.

Maybe the fiscal cliff has been dealt with but it are we still gonna see a struggle on the global level.

Well yes I think we're seeing deceleration around the world.

Really based on the the fact a lot of gross had been due to excess borrowing which now has to be retrenched.

And I think -- as we get into next year we'll see the US continued to accelerate because we have strength in housing and autos.

And also our -- our employment is picking up.

But I think that will see gross rather muted -- returns next year will be muted but still a lot better than the risk free alternatives.

When it places Europe pointing your investors -- -- -- shale gas revolution.

Can you -- -- -- about -- and where people should be looking to put their money.

Well I think that the -- -- the whole spectrum as attractive whether they are companies.

That have a lot of their assets in shale gas -- certainly.

To have assets in the US look a lot less risky than some of the overseas energy assets or companies to a pipeline companies who transport store treat.

Shale gas in shale gas liquids.

As well as companies that can use these low cost products as -- as eighty as a resource before their products such as some the basic chemical companies which have a terrific outlook now.

Based on low cost -- -- And very quickly might be what about the pharmaceutical assay do you -- -- -- -- think there's some big new products coming down the pipeline and this might be a good area for investment.

Yes I think that even big farm -- looks very interesting.

Because they still have an opportunity to develop new drugs and connect revenues in spite of some of their patents coming off over the next few years.

Also they have a tremendous opportunity to cut costs and so increase cash flow.

And then we have specialty pharma companies that are much smaller but have more proprietary products that won't be hurt by any kind of price caps and health care.

We don't know what's gonna happen as far as obamacare.

And also have a chance to be acquired Lucy -- -- -- -- activity that is and very beneficial very good great information Margie Patel thank you so much for joining us.